Chicago Capital Management’s Verona Pharma VRNA Stock Holding History

Chicago Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-129,600	Closed	-$13.8M	–	49
2025 Q3	$13.8M	Buy	+129,600	New	+$13.5M	12.37%	1

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Chicago Capital Management's VRNA Position: Q4 2025 in Review

Chicago Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 129,600 shares — an estimated $13.8M sold.

Chicago Capital Management first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $13.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Chicago Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Chicago Capital Management sold 129,600 Verona Pharma shares in Q4 2025, an estimated $13.8M.
Chicago Capital Management first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Chicago Capital Management's Verona Pharma position peaked at $13.8M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Chicago Capital Management's 13F filing for Q4 2025, filed 2 Feb 2026.